All In MedTech

Device Trial Radar · NCT02767284

A Comparative Study of Six Methods to Measure Human Contrast Vision

UCST Studie 1 - Jämförande Studie Mellan några Befintliga Och Nyutvecklade Metoder för Att mäta Den Spektrala kontrastkänslighetsfunktionen Hos människa

Last checked: Nov 19, 2026Latest source record: Jun 28, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Jun 2016

Primary completion

Jun 2017

Study completion Oct 2017

Sponsor

Lead sponsor
Uppsala UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 10, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study evaluates the relative performance of different methods to measure the human spectral contrast sensitivity function (CSF).

Conditions

  • Methods to Measure Contrast Vision

Interventions

  • UCST-V1Device

    A previously developed device, Uppsala Contrast Sensitivity Tester - UCST-V1, that quickly measures the human CSF in one stimulus.

  • UCST-V2Device

    A refined version of the UCST-V1 that randomizes frequency order.

  • UCST-V3Device

    A version that utilises eye-tracking technology to make the measurements more accurate.

  • Quick-CSF (QCSF)Device

    A fast contrast sensitivity measurement method using a Bayesian algorithm.

  • Pelli-RobsonDevice

    A standard method developed using a Sloan-letter chart with decreasing contrast.

  • Optec 6500Device

    A standard test using sinusoidal gratings to measure the contrast sensitivity function.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average time (in seconds) used to measure the contrast sensitivity function for one eye for each methodTime frame: At end of data collection (up to 12 months after first subject is included)
  2. Average area under the curve for the log contrast sensitivity function (AULCSF) in one eye for each methodTime frame: At end of data collection (up to 12 months after first subject is included)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Uppsala University Hospital

    Uppsala, Sweden · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.